6 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
inhibitors in CVD ... HF outcomes in HFrEF ... on GDMT, with or ... HF outcomes in HFrEF ... SGLT2 #inhibitors #EBM
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
) in HFrEF and CKD ... therapies" for HFrEF ... used in HFrEF: ... Statins, Thiazides ... #CKD #HFrEF #management
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... #HeartFailure #Staging
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
Iron Deficiency ... functional ID) Treatment ... mortality and CV ... #HFrEF #heartfailure ... #diagnosis #management
HFpEF and CAD Management Algorithm
1. Consider revascularization based on current guidelines for CAD and HFpEF*
2. Statins:
HFpEF and CAD Management ... guidelines for CAD ... and HFpEF* 2. ... Enroll in HFpEF ... #HFpEF #CAD #Management
Adult-Onset Still's Disease
Clinical triad: Fever, Arthralgia/arthritis, Skin rash ± odynophagia
+ Biological inflammation: Increased neutrophils, Hyperferritinemia, decreased
Disease Clinical triad ... mevalonate kinase deficiency ... hepatitis • Pulmonary ... Disease #diagnosis #management ... #treatment #rheumatology